🔓 Everything Pass · unlock every paragraph + the whole catalog for $29Get the Pass →
22-brain-chemistry
This is the technical specification. The deliverable it describes is the full 22-brain-chemistry blueprint package.
Enterprise blueprint packages settle by wire transfer — their value is above any card ceiling. Request the package below and a reference number is emailed to you straight away. The package ships to you on a Blu-ray disc once the wire clears, so include the address it should be mailed to.
Prefer the store page? Open the full product page.
Read the whole thing. Unlock all 12 locked sections of this description in one purchase.
Buy the whole description for $22.80
Inventor: Christopher Gabriel Brown
U.S. Patent Application No.: 19/555,525 — 24 claims, Confirmation No. 9226
Filed: March 3, 2026 | Entity: Micro Entity (sole inventor)
Title of Invention: Multi-Element Neurotherapeutic Composition With Formulation Method and Computational Method for Designing Multi-Target Brain Disease Treatments
Status: Pending examination at the United States Patent and Trademark Office (USPTO). This is not a granted patent.
Priority chain: Prov. 63/552,008 (2024-02-09) → 18/650,137 (2024-04-30) → 19/031,884 (2025-01-18) → 19/177,547 (2025-04-12) → 19/555,525 (2026-03-03)
Research duration: ∼20 years
SKU: 2051 | Package ID: 22-brain-chemistry | Version: 1.0.0
U.S. Patent Application No.: 19/555,525 — 24 claims, Confirmation No. 9226
Filed: March 3, 2026 | Entity: Micro Entity (sole inventor)
Title of Invention: Multi-Element Neurotherapeutic Composition With Formulation Method and Computational Method for Designing Multi-Target Brain Disease Treatments
Status: Pending examination at the United States Patent and Trademark Office (USPTO). This is not a granted patent.
Priority chain: Prov. 63/552,008 (2024-02-09) → 18/650,137 (2024-04-30) → 19/031,884 (2025-01-18) → 19/177,547 (2025-04-12) → 19/555,525 (2026-03-03)
Research duration: ∼20 years
SKU: 2051 | Package ID: 22-brain-chemistry | Version: 1.0.0
NeuroElement is a patent-pending, computationally designed seven-compound brain-optimization formulation that delivers 10 of 14 brain-essential chemical elements through bioavailable, blood-brain-barrier-crossing forms. The formulation was designed using a proprietary algorithmic method that systematically analyses 54 diseases, 65 neurotransmitters, and 40 neurobiochemical mechanisms to identify the combination of elements with the highest combined mechanism-coverage and disease-coverage scores.
The deliverable is not a supplement bottle. It is the complete research-and-engineering source tree — Python analysis platform, structured JSON databases, patent-application documents, formulation specification, dosing schedule, manufacturing notes, FDA-compliant Supplement Facts generator, CLI and REST-API tooling, 7 research reports, and 9 patent-drawing SVGs — everything required to evaluate, reproduce, manufacture, and commercialise the formulation.
Read section 3 for $1.90
The inventor constructed comprehensive databases covering 65 neurotransmitters, 20 brain-critical elements, 54 brain diseases (in 18 major categories), 40 identified neurobiochemical mechanisms, and 35 clinically approved brain medicines across four evolutionary categories. A six-step computational pipeline selects the element combination with the highest joint mechanism × disease score, then maps each element to a specific bioavailable delivery compound capable of crossing the blood–brain barrier.
Read section 4 for $1.90Key dosing rationale:
Read section 5 for $1.90
A key finding of the research is the Dopamine Assembly Line — a sequential metallic-cofactor pathway required for dopamine synthesis, conversion, and transport:
Read section 6 for $1.90
No existing Parkinson’s disease therapy supplies the metallic cofactors the dopamine assembly line requires. The NeuroElement formulation addresses steps 1 and 3 directly via Iron Bisglycinate and Zinc Carnosine; step 2 is supported by dietary copper.
Read section 7 for $1.90
The database reveals that three independent timelines — evolutionary age, historical drug-discovery order, and pharmacokinetic onset speed — all converge on an identical ordering across four brain-medicine categories:
Read section 8 for $1.90
The package ships a production-quality Python research platform (v1.0.0) requiring no dependencies beyond the standard library for CLI usage. An optional REST API layer uses FastAPI + Uvicorn.
Read section 9 for $1.90
A formal pre-proposal letter was submitted on March 3, 2026 to The Michael J. Fox Foundation for Parkinson’s Research and to Dr. Mitesh Bhakta, PharmD (compounding pharmacist), outlining the Dopamine Assembly-Line discovery and requesting scientific evaluation and pharmaceutical compounding partnership.
Read section 10 for $1.90Key deliverable artefacts:
Read section 11 for $1.90This package ships on a single Blu-ray disc, posted to the delivery address on your order. The archive on the disc is AES-256 encrypted; the passphrase is sent separately, by email, once the disc is despatched — so the disc alone is of no use to anyone who intercepts it.
Read section 12 for $1.90Discs are despatched by tracked, signed-for post. Allow 5 business days for mastering and verification before despatch.
Read section 13 for $1.90
© 2026 Christopher Gabriel Brown. All rights reserved.
NeuroElement™ is a product designation of the inventor. U.S. Patent Application 19/555,525 — patent pending.
No intellectual property is conveyed with purchase. The underlying copyrighted material, the method-claim patent strategy, and the “Cri-One” and “NeuroElement” marks remain the property of Christopher Gabriel Brown.
Read section 14 for $1.90NeuroElement™ is a product designation of the inventor. U.S. Patent Application 19/555,525 — patent pending.
No intellectual property is conveyed with purchase. The underlying copyrighted material, the method-claim patent strategy, and the “Cri-One” and “NeuroElement” marks remain the property of Christopher Gabriel Brown.